Biomaterial Wound Dressing Global Market Report 2024

The biomaterial wound dressing market size has grown strongly in recent years. It will grow from $5.34 billion in 2023 to $5.74 billion in 2024 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to several factors. Firstly, the biocompatibility of biomaterials used in wound dressings has contributed significantly to their adoption. Secondly, biomaterial wound dressings offer cost-effective solutions compared to traditional wound care methods, making them attractive to healthcare providers and patients alike. Thirdly, growing environmental concerns have driven the development of biodegradable wound dressings, aligning with sustainability goals in healthcare. Additionally, there has been an increased demand for specialized wound care products, including dressings, due to factors such as aging populations and rising incidences of chronic wounds. Finally, the heightened focus on infection control has led to the widespread use of antimicrobial biomaterial dressings, further driving their growth in the historic period.

The biomaterial wound dressing market size is expected to see strong growth in the next few years. It will grow to $7.73 billion in 2028 at a compound annual growth rate (CAGR) of 7.7%. The historic period's growth stems from several factors, biomaterials' biocompatibility, the cost-effectiveness of biomaterial wound dressings versus traditional methods, rising environmental concerns driving biodegradable wound solutions, heightened demand for specialized wound care products, and a stronger emphasis on infection control through antimicrobial biomaterial dressings.

The biomaterial wound dressing market is poised for growth due to the increasing number of surgeries. Surgeries, which involve making incisions to address injuries, diseases, or deformities, are on the rise due to factors such as the prevalence of chronic illnesses, wider health insurance coverage, growing medical tourism, and advancements in healthcare. Biomaterial wound dressings play a crucial role by acting as a protective barrier against pathogens, thereby reducing the risk of surgical site infections (SSIs). For instance, in September 2023, the American Society of Plastic Surgeons (ASPS) reported a significant increase in cosmetic surgical treatments, indicating a rising trend in surgeries driving demand for such products.

Key players in the biomaterial wound dressing market are focusing on developing targeted wound treatments for more effective and convenient solutions. Targeted wound treatments are tailored medical therapies designed to meet the specific needs of different types of wounds. For instance, researchers from the California Institute of Technology introduced the Smart Bandage in March 2023, which accelerates the healing of chronic infected wounds such as diabetic ulcers. These bandages are made from a flexible, elastic polymer embedded with electronics and drugs. Equipped with sensors, they can detect inflammation and infection by monitoring indicators such as uric acid, lactate, pH, and temperature. Additionally, they can deliver antibiotics or other treatments directly to the wound site using drug-loaded hydrogels.

In March 2022, Convatec Group plc, a UK-based medical products and technologies company, acquired Triad Life Sciences Inc. This acquisition strengthens Convatec's position in the advanced wound care sector, particularly in wound biologics. Triad Life Sciences Inc., a US-based biotechnology company, specializes in providing biologically-derived products to address clinical needs in surgical wounds.

Major companies operating in the biomaterial wound dressing market are McKesson Medical-Surgical Inc., Johnson & Johnson, The 3M Company, Medtronic plc, Baxter International, Medline Industries LP, B. Braun SE, Smith & Nephew plc, Milliken Healthcare Products LLC, Coloplast A/S, Mölnlycke Health Care AB, Integra LifeSciences, Lohmann & Rauscher International GmbH & Co. KG, Hollister Incorporated, DeRoyal Industries Inc., Advanced Medical Solutions Group, Tyndall National Institute, URGO MEDICAL, BSN Medical, Gentell, Dukal LLC, Covalon Technologies, Argentum Medical LLC, PolyMedics Innovations Inc., Spenco Medical Corporation.

North America was the largest region in the biomaterial wound dressing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biomaterial wound dressing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the biomaterial wound dressing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Biomaterial wound dressings are wound care products crafted from natural or synthetic materials that are compatible with the human body. These dressings are intended to cover and safeguard wounds, promote healing, and create an appropriate environment for tissue regeneration. They can vary in composition and structure, with some incorporating advanced features such as antibacterial properties, moisture retention capabilities, and the ability to conform to the wound site for optimal healing.

The main types of biomaterial wound dressings include hydrogel dressings, alginate dressings, hydrocolloid dressings, and skin substitutes. Hydrogel dressings consist of a network of hydrophilic polymers that can retain significant amounts of water, fostering a moist environment conducive to wound healing. They find applications in various scenarios such as burns, pressure ulcers, surgical wounds, lacerations, cuts, and skin grafts, and are utilized by various end users such as hospitals, clinics, ambulatory surgical centers, and homecare settings.

The biomaterial wound dressing market research report is one of a series of new reports that provides biomaterial wound dressing market statistics, including the biomaterial wound dressing industry global market size, regional shares, competitors with biomaterial wound dressing market share, detailed biomaterial wound dressing market segments, market trends, and opportunities, and any further data you may need to thrive in the biomaterial wound dressing industry. This biomaterial wound dressing market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The biomaterial wound dressing market consists of sales of collagen dressings, chitosan dressings, silicone-based dressings, foam dressings, film dressings, and composite dressings. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.